World's Best Scientists 2026 revealed!
Tim H. Brümmendorf

Tim H. Brümmendorf

D-Index & Metrics

Biology and Biochemistry

D-Index
68
Citations
17462
World Ranking
7753
National Ranking
566

Overview

Tim H. Brümmendorf is affiliated with RWTH Aachen University in Germany. Their research primarily focuses on the field of medicine, with a particular concentration in hematology, genetics, and molecular biology. Their scholarly work covers various topics in oncology and physiology as well.

The subfields deeply explored in their research include:

  • Hematology
  • Genetics
  • Molecular Biology
  • Oncology
  • Physiology

The principal research topics addressed by Brümmendorf encompass:

  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Acute Myeloid Leukemia Research
  • Eosinophilic Disorders and Syndromes
  • Telomeres, Telomerase, and Senescence
  • Acute Lymphoblastic Leukemia Research

Their publication record includes contributions to several well-known journals, notably:

  • Blood
  • Leukemia
  • HemaSphere
  • Clinical Lymphoma Myeloma & Leukemia
  • Blood Advances

Recent papers that exemplify Brümmendorf's research focus include:

  • Bosutinib versus imatinib for newly diagnosed chronic phase chronic myeloid leukemia: final results from the BFORE trial, 2022, Leukemia
  • Dexamethasone nanomedicines for COVID-19, 2020, Nature Nanotechnology
  • CEBPA mutations in 4708 patients with acute myeloid leukemia: differential impact of bZIP and TAD mutations on outcome, 2021, Blood
  • Heterogeneous bone-marrow stromal progenitors drive myelofibrosis via a druggable alarmin axis, 2020, Cell stem cell
  • Does time from diagnosis to treatment affect the prognosis of patients with newly diagnosed acute myeloid leukemia?, 2020, Blood

Their frequent co-authors, with whom they have collaborated extensively, include:

  • Steffen Koschmieder
  • Andreas Hochhaus
  • Fabian Beier
  • Susanne Isfort
  • Andreas Burchert

Best Publications

  • Aging of blood can be tracked by DNA methylation changes at just three CpG sites.

    Carola Ingrid Weidner;Qiong Lin;Carmen Maike Koch;Lewin Eisele

  • Telomere Fluorescence Measurements in Granulocytes and T Lymphocyte Subsets Point to a High Turnover of Hematopoietic Stem Cells and Memory T Cells in Early Childhood

    Nathalie Rufer;Tim H. Brümmendorf;Steen Kolvraa;Claus Bischoff

  • Bosutinib Versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia: Results From the BELA Trial

    Jorge E. Cortes;Dong Wook Kim;Hagop M. Kantarjian;Tim H. Brümmendorf;Tim H. Brümmendorf

  • Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): a prespecified interim analysis of a prospective, multicentre, non-randomised, trial

    Susanne Saussele;Johan Richter;Joelle Guilhot;Franz X Gruber

  • Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib

    Jorge E. Cortes;Hagop M. Kantarjian;Tim H. Brümmendorf;Dong Wook Kim

  • Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial

    Jorge E. Cortes;Carlo Gambacorti-Passerini;M. W. Deininger;Michael J. Mauro

  • Bosutinib is active in chronic phase chronic myeloid leukemia after imatinib and dasatinib and/or nilotinib therapy failure

    H. Jean Khoury;Jorge E. Cortes;Hagop M. Kantarjian;Carlo B. Gambacorti-Passerini

  • Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

    Rüdiger Hehlmann;Michael Lauseker;Susanne Saußele;Markus Pfirrmann

  • HER-2 amplification is highly homogenous in gastric cancer

    Andreas H. Marx;Lars Tharun;Johanna Muth;Ana-Maria Dancau

  • Telomere length in leukocyte subpopulations of patients with aplastic anemia

    Tim H. Brümmendorf;Jaroslaw P. Maciejewski;Jaroslaw P. Maciejewski;Jennifer Mak;Jennifer Mak;Neal S. Young;Neal S. Young

  • Statins Enhance Migratory Capacity by Upregulation of the Telomere Repeat-Binding Factor TRF2 in Endothelial Progenitor Cells

    Ioakim Spyridopoulos;Judith Haendeler;Carmen Urbich;Tim H. Brummendorf

  • Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry

    Tim H. Brümmendorf;Tessa L. Holyoake;Nathalie Rufer;Michael J. Barnett

  • Rps14 haploinsufficiency causes a block in erythroid differentiation mediated by S100A8 and S100A9

    Rebekka K Schneider;Rebekka K Schneider;Monica Schenone;Monica Ventura Ferreira;Rafael Kramann

  • Prospective study of rabbit antithymocyte globulin and cyclosporine for aplastic anemia from the EBMT Severe Aplastic Anaemia Working Party.

    Judith C. Marsh;Andrea Bacigalupo;Hubert Schrezenmeier;Andre Tichelli

  • Simultaneous targeting of Aurora kinases and Bcr-Abl kinase by the small molecule inhibitor PHA-739358 is effective against imatinib-resistant BCR-ABL mutations including T315I.

    Artur Gontarewicz;Stefan Balabanov;Gunhild Keller;Riccardo Colombo

  • Bosutinib versus imatinib in newly diagnosed chronic‐phase chronic myeloid leukaemia: results from the 24‐month follow‐up of the BELA trial

    Tim H. Brümmendorf;Tim H. Brümmendorf;Jorge E. Cortes;Cármino Antonio de Souza;Francois Guilhot

  • Imatinib mesylate affects the development and function of dendritic cells generated from CD34+ peripheral blood progenitor cells.

    Silke Appel;Andreas M. Boehmler;Frank Grünebach;Martin R. Müller

  • Asymmetric Cell Divisions Sustain Long-Term Hematopoiesis from Single-sorted Human Fetal Liver Cells

    Tim H. Brummendorf;Wieslawa Dragowska;J.Mark J.M. Zijlmans;Gayle Thornbury

  • Low Level Her2 Overexpression Is Associated with Rapid Tumor Cell Proliferation and Poor Prognosis in Prostate Cancer

    Sarah Minner;Birte Jessen;Lars Stiedenroth;Eike Burandt

  • Bosutinib safety and management of toxicity in leukemia patients with resistance or intolerance to imatinib and other tyrosine kinase inhibitors.

    Hagop M. Kantarjian;Jorge E. Cortes;Dong Wook Kim;H. Jean Khoury

Frequent Co-Authors

Carlo Gambacorti-Passerini
Carlo Gambacorti-Passerini University of Milano-Bicocca
Andreas Hochhaus
Andreas Hochhaus Friedrich Schiller University Jena
Jorge E. Cortes
Jorge E. Cortes Augusta University
Hagop M. Kantarjian
Hagop M. Kantarjian The University of Texas MD Anderson Cancer Center
Lothar Kanz
Lothar Kanz University of Tübingen
Hermann Einsele
Hermann Einsele University of Würzburg
Wolfgang E. Berdel
Wolfgang E. Berdel University of Münster
Tessa L. Holyoake
Tessa L. Holyoake University of Glasgow
Satu Mustjoki
Satu Mustjoki University of Helsinki

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Expanding your studies in Biology and Biochemistry opens doors to a variety of online degree programs and career options in the health and life sciences. Students with a foundation in these areas may progress to advanced roles by pursuing specialized education online.

For example, many professionals interested in leadership or policy can explore doctoral programs for healthcare administration, which focus on advanced management skills within healthcare systems. Those aiming for pharmaceutical careers can consider enrolling in a best online pharmacy school to gain high-level expertise in drug development, clinical practice, and research.

For students passionate about physical health and sports, earning a sports science degree online provides a path to careers in fitness, athletic coaching, or rehabilitation. Similarly, those seeking to accelerate their entry into the field may benefit from an accelerated kinesiology degree online to quickly qualify for work in exercise therapy, sports medicine, or wellness.

With these flexible online pathways, students can tailor their further education to their interests and career goals—all while benefiting from the convenience and accessibility of remote learning.

Best Scientists Citing Tim H. Brümmendorf

Trending Scientists

Recently Published Articles